Analytical & Bioanalytical Method Validation

Global Regulatory Expectations for Microbiological and Sterility Method Validation

Global Regulatory Expectations for Microbiological and Sterility Method Validation Microbiological and sterility testing are critical components in the pharmaceutical and biotechnology industries, necessary to ensure product safety and efficacy. With the global landscape of regulatory requirements constantly evolving, it is essential for pharmaceutical professionals to have a robust understanding of the various expectations set forth by prominent regulatory agencies such…

Continue Reading Global Regulatory Expectations for Microbiological and Sterility Method Validation

Outsourcing Microbiological Method Validation to Contract Labs – Oversight and QA

Outsourcing Microbiological Method Validation to Contract Labs – Oversight and QA Outsourcing Microbiological Method Validation to Contract Labs – Oversight and QA Outsourcing microbiological method validation has become a prevalent practice in the pharmaceutical industry. This article provides a comprehensive review of the regulatory expectations surrounding this process in line with various global guidelines, namely US FDA Process Validation guidance…

Continue Reading Outsourcing Microbiological Method Validation to Contract Labs – Oversight and QA

Robustness Testing of Microbial Enumeration Methods Under GMP

Robustness Testing of Microbial Enumeration Methods Under GMP Robustness Testing of Microbial Enumeration Methods Under GMP In the pharmaceutical industry, microbial enumeration is essential for ensuring the quality and safety of products. Robustness testing for enumeration methods is a critical part of the validation process for microbiological methods, reflecting regulatory expectations from authorities like the US FDA, EMA, MHRA, and…

Continue Reading Robustness Testing of Microbial Enumeration Methods Under GMP

Recovery of Stressed Organisms in Microbiological Method Validation

Recovery of Stressed Organisms in Microbiological Method Validation The validation of microbiological methods is a critical process for ensuring the reliability and safety of pharmaceutical products. One key aspect of this validation is the use of stressed organisms to evaluate the robustness of the methods employed. Stressed organism recovery studies are essential for demonstrating the capability of microbiological methods to…

Continue Reading Recovery of Stressed Organisms in Microbiological Method Validation

Validation of Sterility Testing Isolators and Closed Aseptic Systems

Validation of Sterility Testing Isolators and Closed Aseptic Systems Validation of Sterility Testing Isolators and Closed Aseptic Systems Validation of sterility testing isolators and closed aseptic systems is a critical component in ensuring the sterility and safety of pharmaceutical products. Regulatory agencies such as the US FDA, EMA, MHRA, and PIC/S provide stringent guidelines and expectations that must be adhered…

Continue Reading Validation of Sterility Testing Isolators and Closed Aseptic Systems

Apparatus Selection and Method Parameters in Dissolution Method Validation

Apparatus Selection and Method Parameters in Dissolution Method Validation Dissolution testing is a critical aspect of pharmaceutical development and quality control, serving as a predictive tool for drug bioavailability and absorption. Ensuring the validity of dissolution methods is essential for compliance with regulatory guidelines such as those established by the FDA, EMA, and other health authorities. This article offers a…

Continue Reading Apparatus Selection and Method Parameters in Dissolution Method Validation

Validation of Dissolution Methods for Modified-Release and Delayed-Release Products

Validation of Dissolution Methods for Modified-Release and Delayed-Release Products Understanding MR/DR Dissolution Validation Dissolution testing serves as a critical quality control mechanism in the pharmaceutical industry, particularly for modified-release (MR) and delayed-release (DR) formulations. Defined by the United States Pharmacopeia (USP), modified release refers to dosage forms designed to release the active ingredient in a manner that alters the timing…

Continue Reading Validation of Dissolution Methods for Modified-Release and Delayed-Release Products

Setting Discriminatory Dissolution Methods That Predict Clinical Performance

Setting Discriminatory Dissolution Methods That Predict Clinical Performance Setting Discriminatory Dissolution Methods That Predict Clinical Performance The development of pharmaceutical formulations is a meticulous process that involves understanding the intricate mechanisms of drug release and absorption. One critical aspect of this process involves establishing discriminatory dissolution methods that can predict clinical performance effectively. This article serves as a comprehensive guide…

Continue Reading Setting Discriminatory Dissolution Methods That Predict Clinical Performance

Dissolution Method Development and Validation for Solid Oral Dosage Forms

Dissolution Method Development and Validation for Solid Oral Dosage Forms Dissolution method validation is an integral part of pharmaceutical quality assurance processes, particularly for solid oral dosage forms such as tablets and capsules. Regulatory guidance from authorities like the US FDA, EMA Annex 15, ICH Q8–Q11, and PIC/S outlines stringent expectations for this process. This article provides a comprehensive overview…

Continue Reading Dissolution Method Development and Validation for Solid Oral Dosage Forms

Biorelevant Dissolution Media and IVIVC Considerations in Method Validation

Biorelevant Dissolution Media and IVIVC Considerations in Method Validation The validation of dissolution testing methods is a critical component of pharmaceutical quality assurance and regulatory compliance. Within this context, biorelevant dissolution media such as FaSSIF (Fasted State Simulated Intestinal Fluid) and FeSSIF (Fed State Simulated Intestinal Fluid) play a pivotal role in bridging in vitro dissolution testing with in vivo…

Continue Reading Biorelevant Dissolution Media and IVIVC Considerations in Method Validation